Indications and uses
For hand washing to decrease bacteria on the skin. Recommended for repeated use.
For hand washing to decrease bacteria on the skin. Recommended for repeated use.
Pump a small amount of foam into palm of hand. Run thoroughly over all surfaces of both hands for 15 seconds Rinse with potable water.
Benzalkonium Chloride 0.13%
Antimicrobial
avoid contact with eyes. In case of eye contact, flush eyes with water.
irritation or redness develops. If condition persists for more than 72 hours.
If swallowed, get medical help or contact a Poison Control Center right away.
Water, (aqua), butylene glycol, Dihydroxypropyl PEG-5 linoleammonium chloride, Dihydroxyethyl cocamine oxide, glycereth-2 cocoate, Hydroxypropyl methylcellulose.
DE Fender SCIENTIFIC MOLECULAR TECHNOLOGIES ANTISEPTIC FOAM Hand Soap ELIMINATES 99.999% OF MOST COMMON GERMS THAT CAUSES ILLNESS NO RINSE MOISTURIZES LEAVES SKIN SOFT 8.4 fl oz (250 ml)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1046593 | benzalkonium chloride 0.13 % Medicated Liquid Soap | PSN | 4 |
| 1046593 | benzalkonium chloride 1.3 MG/ML Medicated Liquid Soap | SCD | 4 |
| 1046593 | benzalkonium chloride 0.13 % Medicated Liquid Soap | SY | 4 |
| 1046593 | benzalkonium chloride 1.33 MG/ML Medicated Liquid Soap | SY | 4 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 42953-000-00 | 2022-07-29 | C162847 | 48780-1 | e4f33bdf-a777-d8a0-e053-dadaa90a6e4e | DEFENDER Antiseptic Foam Hand |
| 42953-000-01 | 2022-07-29 | C162847 | 48780-1 | e4f33bdf-a777-d8a0-e053-dadaa90a6e4e | DEFENDER Antiseptic Foam Hand |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42953-000-00 | DEFENDER Antiseptic Foam Hand | 250 mL in 1 BOTTLE, PUMP | SOAP | 250 | 4 | |
| 42953-000-01 | DEFENDER Antiseptic Foam Hand | 1000 mL in 1 BOTTLE, PUMP | SOAP | 1000 | 4 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BENZALKONIUM CHLORIDE | ACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| BENZALKONIUM | ACTIVE MOIETY | 7N6JUD5X6Y | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| DIHYDROXYETHYL COCAMINE OXIDE | INACTIVE INGREDIENT | 8AR51R3BL5 | 1 | |
| DIHYDROXYPROPYL PEG-5 LINOLEAMMONIUM CHLORIDE | INACTIVE INGREDIENT | 0Y0NQR2GH1 | 1 | |
| GLYCERETH-2 COCOATE | INACTIVE INGREDIENT | JWM00VS7HC | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 42953-000 | 42953-000-00, 42953-000-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| DIHYDROXYPROPYL PEG-5 LINOLEAMMONIUM CHLORIDE | 0Y0NQR2GH1 | IACT |
| DIHYDROXYETHYL COCAMINE OXIDE | 8AR51R3BL5 | IACT |
| GLYCERETH-2 COCOATE | JWM00VS7HC | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c3cb9fff-d3fb-2c23-e053-2995a90aaa09 | d4eb0770-bc69-4801-9e2b-7d96d195f594 | 2021-06-01 | Warnings | c3cb9fff-d3fb-2c23-e053-2995a90aaa09 d4eb0770-bc69-4801-9e2b-7d96d195f594 |
Adverse event summaries are temporarily unavailable. Other product information remains available.